Two major themes cut across the week’s news: the profound integration of advanced technology, particularly Artificial ...

The 2025 PharmSci 360 conference will highlight advances in drug manufacturing, focusing on investment strategies and emerging modalities. Richard Thakor, PhD, will discuss the economics of innovative ...

Editor's note: this interview was originally published on BioPharmInternational.com.

In Episode 28, Miroslav Gasparek, Sensible; Lizzy Lawrence, STAT; and Joe Lewis, Deloitte, go behind the headlines.

Steve will be monitoring the Rapid Fires: AI/ML in Bioanalysis session on Monday, Nov. 10, 2025 at 3PM CT at AAPS PharmSci ...

Tariffs increase operational costs by raising prices for raw materials, APIs, and finished drugs, complicating logistics and ...

CPHI Frankfurt 2025 highlighted a pharmaceutical industry in flux, navigating the rapid acceleration of artificial ...

Frank Romanski of Lonza Capsugel dives into the excipient side of manufacturing and the emerging prevalence of digitalization ...

Vaccine manufacturing is challenged by stringent global regulations, essential for ensuring safety and efficacy, with ...

Kimberly‑Clark said on Nov. 3, 2025 that it is planning to acquire Kenvue, the former Johnson & Johnson unit and maker of ...

Because scope 3 covers the entire value chain, pharma scientists should integrate sustainability into R&D, manufacturing, and ...

In this PharmTech video feature, we highlight the week’s industry news in an easy-to-consume, fun format. New roundups will ...